Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,088 | -86,841 | -39,232 | -223,812 | -145,341 |
| Depreciation Amortization | 1,367 | 819 | 281 | 2,028 | 1,600 |
| Accounts receivable | -39,320 | -17,484 | -8,623 | 1,389 | 1,389 |
| Other Working Capital | -76,608 | -36,500 | -28,324 | -1,647 | -18,657 |
| Other Operating Activity | 69,270 | 38,099 | 15,996 | 45,872 | 8,709 |
| Operating Cash Flow | $-18,203 | $-101,907 | $-59,902 | $-176,170 | $-152,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,896 | 46,501 | -6,168 | -19,999 | -36,271 |
| PPE Investments | N/A | N/A | N/A | -14 | -11 |
| Purchase Of Investment | N/A | -22,168 | N/A | N/A | N/A |
| Investing Cash Flow | $-5,896 | $24,333 | $-6,168 | $-20,013 | $-36,282 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 25,000 | 25,000 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -975 | -975 |
| Common Stock Issued | 47,831 | 47,410 | 363 | 584 | 535 |
| Other Financing Activity | -125 | -125 | -125 | 0 | 0 |
| Financing Cash Flow | $72,706 | $72,285 | $25,238 | $-391 | $-440 |
| Beginning Cash Position | 103,577 | 103,577 | 103,577 | 300,151 | 300,151 |
| End Cash Position | 152,184 | 98,288 | 62,745 | 103,577 | 111,129 |
| Net Cash Flow | $48,607 | $-5,289 | $-40,832 | $-196,574 | $-189,022 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,203 | -101,907 | -59,902 | -176,170 | -152,300 |
| Capital Expenditure | N/A | N/A | N/A | -14 | -11 |
| Free Cash Flow | -18,203 | -101,907 | -59,902 | -176,184 | -152,311 |